The octadecaneuropeptide exerts an anxiogenic-like action in goldfish

Neuroscience

Volumn 181, Issue , 2011, Pages 100-108

  Matsuda, K ^a   Wada, K ^a   Azuma, M ^a   Leprince, J ^b   Tonon, M C ^b   Sakashita, A ^a   Maruyama, K ^a   Uchiyama, M ^a   Vaudry, H ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Anxiogenic like action; Endozepines; Goldfish; I.c.v. injection; Octadecaneuropeptide; Psychomotor activity

Indexed keywords

BENZODIAZEPINE RECEPTOR; COMPLEMENTARY DNA; METABOTROPIC RECEPTOR; OCTADECANEUROPEPTIDE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; GOLDFISH; LOCOMOTION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSYCHOMOTOR ACTIVITY; SIGNAL TRANSDUCTION;

ANIMALS; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; DIAZEPAM BINDING INHIBITOR; DISEASE MODELS, ANIMAL; FEMALE; GOLDFISH; MALE; MOTOR ACTIVITY; NEUROPEPTIDES; PEPTIDE FRAGMENTS;

EID: 79953754290     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.02.058     Document Type: Article

References (60)

1. Alho H., Kolmer M., Harjuntausta T., Helén P. Increased expression of diazepam binding inhibitor in human brain tumors. Cell Growth Differ 1995, 6:309-314.
2. Bender A.S., Hertz L. Octadecaneuropeptide (ODN; "anxiety peptide") displaces diazepam more potently from astrocytic than from neuronal binding sites. Eur J Pharmacol 1986, 132:335-336.
3. Candiani S., Augello A., Oliveri D., Pestarino M. Immunoreactive endozepine-like peptides in the brain and pituitary of the Atlantic hagfish, Myxine glutinosa. Histochem J 2000, 32:415-421.
4. Chang J.L., Tsai H.J. Carp cDNA sequence encoding a putative diazepam-binding inhibitor/endozepine/acyl-CoA-binding protein. Biochim Biophys Acta 1996, 1298:9-11.
5. Compère V., Li S., Leprince J., Tonon M.C., Vaudry H., Pelletier G. Effect of intracerebroventricular administration of the octadecaneuropeptide on the expression of pro-opiomelanocortin, neuropeptide Y and corticotrophin-releasing hormone mRNAs in rat hypothalamus. J Neuroendocrinol 2003, 15:197-203.
6. Costa E., Guidotti A. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci 1991, 49:325-344.
7. Do Rego J.C., Orta M.H., Leprince J., Tonon M.C., Vaudry H., Costentin J. Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. Neuropsychopharmacology 2007, 32:1641-1648.
8. Do Rego J.L., Leprince J., Luu-The V., Pelletier G., Tonon M.C., Vaudry H. Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN11-18) on neurosteroid biosynthesis by hypothalamic explants. J Med Chem 2007, 50:3070-3076.
9. Do Rego J.L., Mensah-Nyagan A.G., Beaujean D., Leprince J., Tonon M.C., Luu-The V., Pelletier G., Vaudry H. The octadecaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of central-type benzodiazepine receptors. J Neurochem 2001, 76:128-138.
10. Duparc C., Lefebvre H., Tonon M.C., Vaudry H., Kuhn J.M. Characterization of endozepines in the human testicular tissue: effect of triakontatetraneuropeptide on testosterone secretion. J Clin Endocrinol Metab 2003, 88:5521-5528.
11. Eipper B.A., Stoffers D.A., Mains R.E. The biosynthesis of neuropeptides: peptide alpha-amidation. Annu Rev Neurosci 1992, 15:57-85.
12. Faganello F.R., Mattioli R. Anxiolytic-like effect of chlorpheniramine in inhibitory avoidance in goldfish submitted to telencephalic ablation. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:269-274.
13. Ferrero P., Costa E., Conti-Tronconi B., Guidotti A. A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brain. Brain Res 1986, 399:136-142.
14. Ferrero P., Guidotti A., Conti-Tronconi B., Costa E. A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacology 1984, 23:1359-1362.
15. Ferrero P., Santi M.R., Conti-Tronconi B., Costa E., Guidotti A. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sci U S A 1986, 83:827-831.
16. 2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. Eur J Pharmacol 1997, 322:275-281.
17. Garcia de Mateos-Verchere J., Leprince J., Tonon M.C., Vaudry H., Costentin J. The octaneuropeptide ODN induces anxiety in rodents: possible involvement of a shorter biologically active fragment. Peptides 1998, 19:841-848.
18. Garcia de Mateos-Verchere J., Leprince J., Tonon M.C., Vaudry H., Costentin J. The octaneuropeptide ODN inhibits apomorphine-induced yawning in rats. Eur J Pharmacol 1998, 357:121-126.
19. Garcia de Mateos-Verchere J., Leprince J., Tonon M.C., Vaudry H., Costentin J. Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN. Peptides 1999, 20:1431-1436.
20. Garcia de Mateos-verchere J., Leprince J., Tonon M.C., Vaudry H., Costentin J. The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. Eur J Pharmacol 2001, 414:225-231.
21. Gray P.W. Molecular biology of diazepam binding inhibitor. Neuropharmacology 1987, 26(7B):863-865.
22. Gray P.W., Glaister D., Seeburg P.H., Guidotti A., Costa E. Cloning and expression of cDNA for human diazepam binding inhibitor, a natural ligand of allosteric regulatory site of the gamma-aminobutyric acid type A receptor. Proc Natl Acad Sci U S A 1986, 83:7547-7551.
23. Grossman L., Utterback E., Stewart A., Gaikwad S., Chung K.M., Suciu C., Wong K., Elegante M., Elkhayat S., Tan J., Gilder T., Wu N., Dileo J., Cachat J., Kalueff A.V. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 2010, 214:277-284.
24. Guidotti A. Role of DBI in brain and its posttranslational processing products in normal and abnormal behavior. Neuropharmacology 1991, 30:1425-1433.
25. Guidotti A., Forchetti C.M., Corda M.G., Konkel D., Bennett C.D., Costa E. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A 1983, 80:3531-3535.
26. Kavaliers M., Hirst M. An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice. Brain Res 1986, 383:343-349.
27. Kragelund B.B., Højrup P., Jensen M.S., Schjerling C.K., Juul E., Knudsen J., Poulsen F.M. Fast and one-step folding of closely and distantly related homologous proteins of a four-helix bundle family. J Mol Biol 1996, 256:187-200.
28. Lamacz M., Tonon M.C., Smih-Rouet F., Patte C., Gasque P., Fontaine M., Vaudry H. The endogenous benzodiazepine receptor ligand ODN increases cytosolic calcium in cultured rat astrocytes. Mol Brain Res 1996, 37:290-296.
29. Leprince J., Cosquer D., Bellemère G., Chatenet D., Tollemer H., Jégou S., Tonon M.C., Vaudry H. Catabolism of the octadecaneuropeptide ODN by prolyl endopeptidase: identification of an unusual cleavage site. Peptides 2006, 27:1561-1569.
30. Leprince J., Gandolfo P., Thoumas J.L., Patte C., Fauchère J.L., Vaudry H., Tonon M.C. Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes. J Med Chem 1998, 41:4433-4438.
31. Leprince J., Oulyadi H., Vaudry D., Masmoudi O., Gandolfo P., Patte C., Costentin J., Fauchère J.L., Davoust D., Vaudry H., Tonon M.C. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Eur J Biochem 2001, 268:6045-6057.
32. Lihrmann I., Plaquevent J.C., Tostivint H., Rajimakers R., Tonon M.C., Conlon J.M., Vaudry H. Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning, and expression in the brain. Proc Natl Acad Sci U S A 1994, 91:6899-6903.
33. Louiset E., Vaudry H., Cazin L. Allosteric modulation of the GABA-induced chloride current in frog melanotrophs. Ann N Y Acad Sci 1993, 680:564-566.
34. Malagon M., Vallarino M., Tonon M.C., Vaudry H. Localization and characterization of diazepam-binding inhibitor (DBI)-like peptides in the brain and pituitary of the trout (Salmo gairdneri). Brain Res 1992, 576:208-214.
35. Malagon M., Vaudry H., Vallarino M., Gracia-Navarro F., Tonon M.C. Distribution and characterization of endozepine-like immunoreactivity in the central nervous system of the frog Rana ridibunda. Peptides 1992, 13:99-107.
36. Malagon M., Vaudry H., Van Strien F., Pelletier G., Gracia-Navarro F., Tonon M.C. Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain. Neuroscience 1993, 57:777-786.
37. Maruyama K., Konno N., Ishiguro K., Wakasugi T., Uchiyama M., Shioda S., Matsuda K. Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and inhibitory effect of a deduced NMU on food intake and locomotor activity. J Neuroendocrinol 2008, 20:71-78.
38. Matsuda K., Kang K.S., Sakashita A., Yahashi S., Vaudry H. Behavioral effect of neuropeptides related to feeding regulation in fish. Ann N Y Acad Sci 2011, 1220:117-126.
39. Matsuda K., Kojima K., Wada K., Maruyama K., Leprince J., Tonon M.C., Uchiyama M., Vaudry H. The anorexigenic action of the octadecaneuropeptide (ODN) in goldfish is mediated through the MC4R- and subsequently the CRH receptor-signaling pathways. J Mol Neurosci 2010, 42:74-79.
40. Matsuda K., Maruyama K., Miura T., Uchiyama M., Shioda S. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection. Neurosci Lett 2005, 386:9-13.
41. Matsuda K., Maruymaa K., Nakamachi T., Miura T., Shioda S. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake and locomotor activity in the goldfish, Carassius auratus. Ann N Y Acad Sci 2006, 1070:417-421.
42. Matsuda K., Miura T., Kaiya H., Maruyama K., Uchiyama M., Kangawa K., Shioda S. Stimulatory effect of n-octanoylated ghrelin on locomotor activity in the goldfish, Carassius auratus. Peptides 2006, 27:1335-1340.
43. Matsuda K., Wada K., Miura T., Maruyama K., Shimakura S.I., Uchiyama M., Leprince J., Tonon M.C., Vaudry H. Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish. Neuroscience 2007, 150:425-432.
44. Maximino C., Marcues de Brito T., Dias C.A., Gouveia A., Morato S. Scotaxis as anxiety-like behavior in fish. Nat Protoc 2010, 5:209-216.
45. Maximino C., Marcues de Brito T., Colmanetti R., Pontes A.A., de Castro H.M., de Lacerda R.I., Morato S., Gouveia A. Parametric analyses of anxiety in zebrafish scototaxis. Behav Brain Res 2010, 210:1-7.
46. Nakamachi T., Matsuda K., Maruyama K., Miura T., Uchiyama M., Funahashi H., Sakurai T., Shioda S. Regulation by orexin of feeding behaviour and locomotor activity in the goldfish. J Neuroendocrinol 2006, 18:290-297.
47. Patte C., Vaudry H., Desrues L., Gandolfo P., Strijdveen I., Lamacz M., Tonon M.C. The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes. FEBS Lett 1995, 362:106-110.
48. Pirone A., Giannaccini G., Betti L., Lucacchini A., Mascia G., Fabbrini L., Italiani P., Uccelli A., Lenzi C., Fabiani O. Autoradiographic localization and binding study of benzodiazepines receptor sites in carp brain (Cyprinus carpio L.). J Chem Neuroanat 2006, 31:139-145.
49. Rofojo D., Holsboer F. CRH signaling. Molecular specificity for drug targeting in the CNS. Ann N Y Acad Sci 2009, 1179:106-119.
50. Rotzinger S., Lovejoy D.A., Tan L.A. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 2010, 31:736-756.
51. Roy M., David N.K., Danao J.V., Baribault H., Tian H., Giorgetti M. Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects. Neuropsychopharmacology 2006, 31:112-120.
52. Satoh M., Yokosawa H., Ishii S. Membrane-bound trypsin-like enzyme functioning in degradation of dynorphin in neuroblastoma cells. Purification and characterization. J Biol Chem 1988, 103:493-498.
53. Slobodyansky E., Guidotti A., Wambebe C., Berkovich A., Costa E. Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor: specific action at the Ro 5-4864 recognition site. J Neurochem 1989, 53:1276-1284.
54. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., Marra M.A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A 2002, 99:16899-16903. Mammalian Gene Collection Program Team.
55. Tong Y., Toranzo D., Pelletier G. Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization. Neuropeptides 1991, 20:33-40.
56. Tonon M.C., Adjeroud S., Lamacz M., Louiset E., Danger J.M., Desrues L., Cazin L., Nicolas P., Vaudry H. Central-type benzodiazepines and the octadecaneuropeptide modulate the effects of GABA on the release of α-melanocyte-stimulating hormone from frog neurointermediate lobe in vitro. Neuroscience 1989, 31:485-493.
57. Tonon M.C., Désy L., Nicolas P., Vaudry H., Pelletier G. Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides 1990, 15:17-24.
58. Tonon M.C., Leprince J., Gandolfo P., Compère V., Pelletier G., Malagon M., Vaudry H. Endozepines. Handbook of biologically active peptides 2006, 813-819. Elsevier, Amsterdam, The Netherlands. A.J. Kastin (Ed.).
59. Viereck J.C., Beinfeld M.C. Characterization of a cholecystokinin 8-generating endoprotease purified from rat brain synaptosomes. J Biol Chem 1992, 267:19475-19481.
60. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., Fournier A., Chow B.K., Hashimoto H., Galas L., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 2009, 61:283-287.